menu search

ANIX / ANIXA BIOSCIENCES INC (ANIX) Upgraded to Buy: What Does It Mean for the Stock?

ANIXA BIOSCIENCES INC (ANIX) Upgraded to Buy: What Does It Mean for the Stock?
ANIXA BIOSCIENCES INC (ANIX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Read More
Posted: Sep 21 2023, 13:32
Author Name: Zacks Investment Research
Views: 101840

ANIX News  

ANIXA BIOSCIENCES INC (ANIX) Upgraded to Buy: What Does It Mean for the Stock?

By Zacks Investment Research
September 21, 2023

ANIXA BIOSCIENCES INC (ANIX) Upgraded to Buy: What Does It Mean for the Stock?

ANIXA BIOSCIENCES INC (ANIX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This migh more_horizontal

The 3 Most Undervalued Cheap Stocks to Buy in September 2023

By InvestorPlace
September 11, 2023

The 3 Most Undervalued Cheap Stocks to Buy in September 2023

The United States Treasury Secretary, Janet Yellen, recently expressed her confidence in the economy's ability to recover from the recession without c more_horizontal

What Makes ANIXA BIOSCIENCES INC (ANIX) a New Buy Stock

By Zacks Investment Research
June 22, 2023

What Makes ANIXA BIOSCIENCES INC (ANIX) a New Buy Stock

ANIXA BIOSCIENCES INC (ANIX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This migh more_horizontal

Is Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year?

By Zacks Investment Research
April 25, 2023

Is Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year?

Here is how ANIXA BIOSCIENCES INC (ANIX) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year. more_horizontal

Anixa: I Am More Bullish After Efficacy Data For Its Triple-Negative Breast Cancer Vaccine

By Seeking Alpha
April 18, 2023

Anixa: I Am More Bullish After Efficacy Data For Its Triple-Negative Breast Cancer Vaccine

Anixa: I Am More Bullish After Efficacy Data For Its Triple-Negative Breast Cancer Vaccine more_horizontal

Anixa (ANIX) Falls 25% Despite Positive Breast Cancer Study Data

By Zacks Investment Research
April 18, 2023

Anixa (ANIX) Falls 25% Despite Positive Breast Cancer Study Data

Anixa Biosciences (ANIX) announces positive top-line data from its phase Ia study evaluating the safety of its breast cancer vaccine. However, the sto more_horizontal

Anixa: Making Sense Of A Bullish Move Up In Bearish Biotech Times

By Seeking Alpha
May 11, 2022

Anixa: Making Sense Of A Bullish Move Up In Bearish Biotech Times

Anixa Biosciences has different very interesting programs ongoing, one of which is a breast cancer vaccine trial with a first partial readout at ASCO more_horizontal


Search within

Pages Search Results: